Stereotactic ablative radiation therapy in renal cell carcinoma: From oligometastatic to localized disease

Volume: 117, Pages: 48 - 56
Published: Sep 1, 2017
Abstract
Renal Cell Carcinoma (RCC) has historically been considered a radioresistant cancer, and radiotherapy was usually delivered with a palliative goal. Stereotactic ablative radiotherapy (SABR) allows the delivery of high doses on small treatment volumes in a safe and effective way, thus opening the doors to new applicationsof radiotherapy both in the treatment of the primary and oligometastasic disease. Aim of the current review is to explore the...
Paper Details
Title
Stereotactic ablative radiation therapy in renal cell carcinoma: From oligometastatic to localized disease
Published Date
Sep 1, 2017
Volume
117
Pages
48 - 56
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.